title: Rescue from lethal Shiga toxin 2-induced renal failure with a cell-permeable peptide.
abstract: Intestinal infection with Shiga toxin (Stx)-producing E.coli is a leading cause of hemolytic uremic syndrome and acute renal injury in otherwise healthy children in the US. Antibiotics are contraindicated and a therapeutic priority is agents that act intracellularly against the bacterial toxins that drive kidney injury. Our aim was to evaluate whether intravenous administration of a cell-permeable peptide (TVP) that binds to Stx2 will reduce disease severity and rescue juvenile baboons from a lethal Stx2 dose (50 ng/kg). TVP (5 mg/kg) was delivered i.v. simultaneously with toxin (prevention protocol) or at 6 or 24 h after toxin with daily 1 mg/kg supplements up to day 4 (rescue protocols). Biomarkers were monitored in blood and urine up to 28 days. TVP therapy resulted in either absence of clinical signs of acute kidney injury and normal urine output (prevention), or delayed and reduced BUN and creatinine levels (rescue) with concomitant survival. Delayed peptide administration significantly reduced thrombocytopenia, but surprisingly did not alter anemia even when monitored for 28 days in rescued survivors. This is the first successful cell-permeable therapeutic that counteracts Stx2 lethality in an animal model, which recapitulates many of the human responses to enteric infection.
authors: Department of Pathology and Laboratory Medicine, Boston University School of Medicine, 670 Albany Street, Boston, MA 02118, USA.
authors: Deborah J
authors: DJ
authors: Stearns-Kurosawa
authors: Valta
authors: V
authors: Collins
authors: Scott
authors: S
authors: Freeman
authors: Diann
authors: D
authors: Debord
authors: Kiyotaka
authors: K
authors: Nishikawa
authors: Sun-Young
authors: SY
authors: Oh
authors: Caitlin S
authors: CS
authors: Leibowitz
authors: Shinichiro
authors: S
authors: Kurosawa
references: Pediatr Int. 1999 Apr;41(2):223-7
references: 10221034
references: J Biol Chem. 1989 Jan 5;264(1):596-601
references: 2642481
references: Am J Pathol. 2006 Aug;169(2):433-44
references: 16877346
references: Pediatr Infect Dis J. 1998 Oct;17(10):899-904
references: 9802632
references: Pediatr Nephrol. 2003 Feb;18(2):92-6
references: 12579394
references: Pediatr Nephrol. 2008 Aug;23(8):1303-8
references: 18465151
references: J Infect Dis. 2009 Feb 15;199(4):486-93
references: 19125676
references: J Biol Chem. 2006 Apr 14;281(15):10230-5
references: 16476743
references: Shock. 2000 Feb;13(2):100-9
references: 10670839
references: J Infect Dis. 1989 Dec;160(6):994-8
references: 2685131
references: Pediatr Infect Dis J. 1995 Jul;14(7):594-8
references: 7567288
references: Am J Pathol. 1999 Apr;154(4):1285-99
references: 10233866
references: J Thromb Haemost. 2005 Apr;3(4):752-62
references: 15842359
references: Am J Physiol Gastrointest Liver Physiol. 2009 Jan;296(1):G78-92
references: 18974311
references: J Clin Microbiol. 1999 Nov;37(11):3491-6
references: 10523540
references: Blood. 2001 May 15;97(10):3100-8
references: 11342436
references: J Am Soc Nephrol. 2006 Dec;17(12):3404-14
references: 17082244
references: Infect Immun. 2003 Mar;71(3):1497-504
references: 12595468
references: N Engl J Med. 2000 Jun 29;342(26):1930-6
references: 10874060
references: Am J Physiol. 1995 Feb;268(2 Pt 2):F240-50
references: 7864162
references: Pediatrics. 2006 May;117(5):1656-62
references: 16651320
references: Aliment Pharmacol Ther. 2006 Sep 1;24(5):731-42
references: 16918877
references: J Infect Dis. 2004 Feb 1;189(3):360-8
references: 14745692
references: J Exp Med. 2004 Jul 5;200(1):35-46
references: 15226357
references: Pediatr Int. 1999 Apr;41(2):213-7
references: 10221032
references: Cell Microbiol. 2008 Mar;10(3):770-80
references: 18005243
references: J Pediatr. 1994 Oct;125(4):519-26
references: 7931869
references: J Histochem Cytochem. 2002 Jun;50(6):767-77
references: 12019293
references: Lancet. 2005 Mar 19-25;365(9464):1073-86
references: 15781103
references: FASEB J. 2006 Dec;20(14):2597-9
references: 17065223
references: J Clin Invest. 1998 Jan 15;101(2):372-82
references: 9435309
references: Infect Immun. 2010 Jan;78(1):177-83
references: 19858299
references: Kidney Int. 1998 Oct;54(4):1324-30
references: 9767551
references: J Infect Dis. 2002 Jul 1;186(1):57-63
references: 12089662
references: Arch Dis Child. 1997 Aug;77(2):145-7
references: 9301354
references: Emerg Infect Dis. 2000 Sep-Oct;6(5):458-65
references: 10998375
references: N Engl J Med. 2002 Jan 3;346(1):23-32
references: 11777999
references: J Infect Dis. 2000 May;181(5):1825-9
references: 10823794
references: J Immunol. 2007 Nov 15;179(10):7110-20
references: 17982103
references: Pediatr Nephrol. 2009 May;24(5):1061-4
references: 19085014
references: Infect Immun. 2010 Jun;78(6):2497-504
references: 20308301
references: J Neurogastroenterol Motil. 2010 Oct;16(4):363-73
references: 21103418
references: Infect Immun. 2008 May;76(5):1931-9
references: 18285498
references: Pediatr Nephrol. 2002 Dec;17(12):1053-8
references: 12478357
references: PLoS One. 2007 Nov 14;2(11):e1159
references: 18174909
references: Pediatr Nephrol. 1998 Apr;12(3):226-30
references: 9630043
references: Kidney Int. 2002 Sep;62(3):846-56
references: 12164866
references: Pediatrics. 1997 Jul;100(1):E12
references: 9200386
references: JAMA. 1994 Nov 2;272(17):1349-53
references: 7933395